Recent research has linked prenatal exposure to antidepressants with developmental milestone delays in early childhood.
The participants of the study were obtained from the Danish National Birth Cohort. Out of 904 pregnant women who reported depression, 415 used antidepressant medication, including the antidepressant Effexor, and 489 did not. Researchers then compared certain developmental milestones between the children of those women who took the drugs during pregnancy, and those who did not.
The researchers concluded that “The results of our study suggest an effect of antidepressants exposure on fetal brain development” and added that longer follow-up monitoring of the children is necessary in order to further understand the clinical and public health implications of the results.
Following up on the Effexor increases the risk of miscarriage article, Salient news staff have scoured youtube looking for stories from families affected by the medication. This is what we found:
This last video had theses comments left behind by a visitor
Antidepressants such as Effexor and Pristiq may cause birth defects in newborns, according to information which has been emerging since 2005. Data from various international studies show that some antidepressants may cause birth defects. The FDA has issued warnings about certain antidepressants since 2005, and their capability of causing birth defects.
Birth defects associated with antidepressants:
- Cardiac (heart) defects
- Pulmonary (lung) defects- PPHN
- Neural-tube defects (brain and spinal cord)
- Craniosynostosis (abnormally shaped skull)
- Infant omphalocele (abdominal wall defects)
- Club foot (one or both feet turn downward and inward)
- Anal atresia (complete or partial closure of the anus)
- Cleft lip and cleft palate